Exploring the Role of AKAP12 in Cancer Progression and Therapeutic Implication
Open Access
- 31 March 2025
- journal article
- Published by Drug Targets and Therapeutics (DTT) - Pharmaceutical Society of Korea in Drug Targets and Therapeutics
- Vol. 4 (1) , 59-66
Abstract
Nayun Kim, Joohee Jung. DTT 2025;4:59-66. https://doi.org/10.58502/DTT.25.0002Keywords
This publication has 60 references indexed in Scilit:
- Fisetin induces the upregulation of AKAP12 mRNA and anti-angiogenesis in a patient-derived organoid xenograft modelBiomedicine & Pharmacotherapy, 2023
- AKAP12 promotes cancer stem cell-like phenotypes and activates STAT3 in colorectal cancerClinical and Translational Oncology, 2023
- MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12Biomedicine & Pharmacotherapy, 2020
- LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12International Journal of Clinical Oncology, 2020
- SSeCKS/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3FBiochemical and Biophysical Research Communications, 2017
- Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiologyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12Cancer and Metastasis Reviews, 2012
- The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cellsAngiogenesis, 2012
- Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanomaGenes, Chromosomes and Cancer, 2008
- Autoantibody to Gravin is Expressed More Strongly in Younger and Nonthymomatous Patients with Myasthenia GravisSurgery Today, 2001